Search | IOVS | ARVO Journals

View

Showing 1 – 13 of 13

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Pemafibrate exerts therapeutic effects on retinal damages induced by transient elevation of intraocular pressure via multiple protective pathways

Deokho Lee; Ayaka Nakai; Yukihiro Miwa; Yohei Tomita; Hiromitsu Kunimi; Kazuo Tsubota; Kazuno Negishi; Toshihide Kurihara

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):970 – F0367. doi:

ARVO Annual Meeting Abstract June 2022

Protective effects of a HIF Inhibitor halofuginone on light-induced retinal damage via suppression of HIF/BNIP3 axis

Yukihiro Miwa; Chiho Shoda; Deokho Lee; Kazuno Negishi; Toshihide Kurihara

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):664 – F0118. doi:

ARVO Annual Meeting Abstract July 2019

HIF inhibitor topotecan suppresses choroidal neovascularization and fibroproliferation in mice

Chiho Shoda; Yukihiro Miwa; Ayako Ishida; Satoru Yamagami; Kazuo Tsubota; Toshihide Kurihara

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1254. doi:

ARVO Annual Meeting Abstract July 2019

Garcinia extract inhibiting HIF suppresses laser-induced CNV in mice

Mari Ibuki; Chiho Shoda; Yukihiro Miwa; Kazuo Tsubota; Toshihide Kurihara

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1255. doi:

ARVO Annual Meeting Abstract July 2018

Pemafibrate prevents retinal pathological neovascularization via systemic metabolic cascades in mice

Yohei Tomita; Yukihiro Miwa; maki miyauchi; Ayako Ishida; Hiromitsu Kunimi; Yusaku katada; Kazuo Tsubota; Toshihide Kurihara

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3585. doi:

ARVO Annual Meeting Abstract June 2017

Retinal neurodegeneration and neovascularization are suppressed by HIF inhibitor topotecan in murine models of retinopathy

Yukihiro Miwa; Maki Miyauchi; Ayako Ishida; Yusaku Katada; Hiromitsu Kunimi; Yohei Tomita; Kazuo Tsubota; Toshihide Kurihara

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3460. doi:

ARVO Annual Meeting Abstract June 2017

A selective PPARα modulator has preventive effects in murine models of retinopathy

Yohei Tomita; Yukihiro Miwa; Maki Miyauchi; Ayako Ishida; Hiromitsu Kunimi; Yusaku Katada; Kazuo Tsubota; Toshihide Kurihara

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5197. doi:

ARVO Annual Meeting Abstract June 2017

A neuroprotective effect of HIF inhibitor topotecan in a murine model of retinal ganglion cell degeneration

Hiromitsu Kunimi; Yukihiro Miwa; Yusaku Katada; Kazuo Tsubota; Toshihide Kurihara

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5884. doi:

ARVO Annual Meeting Abstract September 2016

Establishment of retinal ganglion cell-specific gene recombination murine models using tet system

Yusaku Katada; Maki Miyauchi; Yukihiro Miwa; Xiaoyan Jiang; Kiwako Mori; Hidemasa Torii; Kenji F Tanaka; Kazuo Tsubota; Toshihide Kurihara

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):747. doi:

ARVO Annual Meeting Abstract September 2016

HIF inhibitor topotecan suppresses light-induced retinal degeneration in mice

Yukihiro Miwa; Maki Miyauchi; Yusaku Katada; Xiaoyan Jiang; Kiwako Mori; Hidemasa Torii; Kazuo Tsubota; Toshihide Kurihara

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2736. doi:

ARVO Annual Meeting Abstract September 2016

Suppressive effect of metformin against experimental myopia in chick

Hidemasa Torii; Toshihide Kurihara; Xiaoyan Jiang; Yusaku Katada; Yukihiro Miwa; Kiwako Mori; Maki Miyauchi; Yuko Seko; Kazuo Tsubota

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5520. doi:

ARVO Annual Meeting Abstract September 2016

Effects of ultra violet radiation on serum vitamin D levels in chick experimental myopia models

Kiwako Mori; Toshihide Kurihara; Xiaoyan Jiang; Maki Miyauchi; Yusaku Katada; Yukihiro Miwa; Yuko Seko; Hidemasa Torii; Kazuo Tsubota

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5522. doi:

ARVO Annual Meeting Abstract September 2016

An effective and robust murine lens-induced myopia model evaluated with micro-CT imaging

Toshihide Kurihara; Xiaoyan Jiang; Kinya Tsubota; Kiwako Mori; Yukihiro Miwa; Yusaku Katada; Maki Miyauchi; Hidemasa Torii; Kazuo Tsubota

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5746. doi:

Advertisement